Clerio Vision
Funding Round in 2018
Clerio Vision is a medical device company focused on refractive and ophthalmic technologies, including contact lenses and intraocular lenses. The company develops and commercializes next-generation products designed to address safety and performance concerns associated with current refractive procedures. Its laser-induced refractive index correction technology enables modification of the corneal refractive index to improve vision and treatment outcomes, offering physicians potential new options for vision correction. Founded in 2014, Clerio Vision is headquartered in Rochester, New York.
Wellinks
Venture Round in 2017
Wellinks specializes in wearable health technologies designed to enhance clinical outcomes. Founded in 2014, the company is renowned for its innovative smart strap that monitors scoliosis brace wear duration and tightness, empowering patients, parents, and doctors with real-time data for informed treatment decisions.
PosiGen
Venture Round in 2017
PosiGen provides residential renewable energy and energy efficiency solutions. As a Third Party Ownership company, it offers solar systems and energy-efficient retrofits to low- to moderate-income homeowners, helping them reduce utility bills and achieve greater financial autonomy.
The Big Willow
Convertible Note in 2017
The Big Willow, Inc. is a technology company that specializes in designing and developing marketing platforms aimed at enhancing buyer engagement and intent identification. Founded in 2013 and headquartered in Wilton, Connecticut, the company leverages advanced analytics to index content consumption across web sessions, linking off-site behavior to activity data from various marketing and sales tools. Its product offerings include a B2B-centric programmatic advertising platform designed around buyer intent, account-based marketing solutions, and pre-targeted advertising and custom content syndication services. The Big Willow also provides marketing technology solutions that drive account-based marketing initiatives and sales enablement solutions to expedite deal flow and increase revenue from qualified leads. By processing vast amounts of web data, the company helps clients uncover buying intent and optimize their marketing strategies to improve engagement with potential customers.
PCC Technology Group
Venture Round in 2014
PCC Technology Group, LLC specializes in providing business domain expertise and information technology solutions tailored for various industries, including healthcare, public sector, utilities, and manufacturing. The company offers a comprehensive range of services, including application outsourcing, project management, compliance management, and professional consulting. Its application outsourcing services encompass development, maintenance, re-platforming, performance management, and quality assurance. In addition, PCC Technology Group delivers project management frameworks, needs assessment deliverables, and compliance services such as auditing, reporting, and performance management. The firm also focuses on content and document management, eGovernance, system integration, and strategic planning. With a strong emphasis on cloud-based applications and components, the company aims to support targeted industries and system integrators effectively.
iCardiac Technologies, Inc. is a specialized provider of cardiac safety biomarkers, focused on enhancing the efficiency of drug development programs. Founded in 2006 and headquartered in Rochester, New York, the company offers a range of services including ECG analysis, statistical reporting, and regulatory interface, all aimed at assessing the cardiac safety profile of drugs in clinical trials. Its flagship product, Dynamic QTbtbsm, comprises ECG-based cardiac safety markers that set new standards for precision and accuracy in human drug trials. iCardiac serves pharmaceutical, biotechnology, and medical device companies by ensuring that clinical trials are conducted with the utmost rigor, helping to appropriately include or exclude study subjects based on cardiac safety considerations.